AMAG Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Dec. 20, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the 36^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time), in San Francisco, California.

To access the live webcast of the presentation and following breakout session please visit the Investors section of the AMAG website at www.amagpharma.com.  A replay of the presentation will be archived on the AMAG website until February 9, 2018.

About AMAG
AMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women’s health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals^® is a registered trademark of AMAG Pharmaceuticals, Inc. CBR^® is a registered trademark of Cbr Systems, Inc.

AMAG Pharmaceuticals Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638